Compromised chronic efficacy of a glucokinase activator AZD1656 in mouse models for common human GCKR variants.

AZD1656 - Conduit Pharmaceuticals

http://www.ncbi.nlm.nih.gov/pubmed/39173844

Ahmed Alshawi; Brian E Ford; David M Smith; Dina Tiniakos; Fiona Oakley; Loranne Agius; Rebecca J Fairclough; Shruti S Chachra

Aug 23, 2024